Manhattan Psychiatric Center
New York, New York 10605
2 studies enrolling now · 16 studies all time
What they study most
Aggression, Auditory Hallucination, Bipolar Disorder, Cognitive Deficits, Emotion, Impulsive Aggression, Impulsivity, Nicotine Dependance, Psychotic Disorders, Schizoaffecitve Disorder, Schizoaffective Disorder, Schizophrenia
Studies at this site
- A Virtual Reality Mindfulness Application for Aggression in Schizophrenia — Recruiting now
- Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial — Recruiting now
- A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia — Completed
- A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia — Completed
- A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® — Stopped early
- Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training — Completed
- Can Cognitive Training Decrease Reactive Aggression? — Completed
- Varenicline Effects In Schizophrenic Smokers — Completed
- Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations — Completed
- Cognitive Skills Training Using Computer for Patients With Severe Mental Illness — Completed
- Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia — Completed
- High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder — Completed
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia — Completed
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. — Completed
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder — Completed
- Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness — Completed